Oliver Rosenthal Email & Phone Number

Hamburg, Hh, De

Bad Homburg, Hessen, De

Global end-to-end P/L responsibility for our R&D, Production and Marketing operations around the world specialised on acute care care products and IT services for infusion therapies in hospital, ambulatory and home care settings.

Bad Homburg, Hessen, De

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.

Gothenburg, Se

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system.The Business Category Acute Care Therapies (ACT) offers integrated solutions for life and limb-threatening health conditions by combining cardiac, pulmonary and vascular therapies. Along with ICU-related equipment, Getinge Group offers a thorough range of products for life support in acute health conditions.Here:Definition and execution of the global marketing strategy for the division ACT with marketing teams in Sweden (Stockholm), Germany (Rastatt and Munich) and the USA (Merrimack/NH and Wayne/PA). Responsible for the commercial business management, product positioning and specification of all products and services for Getinge’s product portfolios in cardio pulmonary (eg heart lung machines, oxygenator range, heat/cooler units), cardio vascular (eg stents, implantable grafts, intra-aortic balloon pumps) and critical care (eg intensive care ventilators, anesthesia machines, advanced hemodynamic patient monitoring solutions for cardiology, diabetes and lactose management).

Gothenburg, Se

Maquet is part of the Swedish-based Getinge Group and accounts for a major portion of the Group’s Net Sales and Getinge’s EBITA. Maquet is one of three Getinge franchises and has recently been relaunched under the Getinge division Acute Care Therapies (ACT) and in the context of a corporate re-organisation to streamline all businesses worldwide.The Business Unit Maquet Critical Care (MCC) develops, produces and markets high-end and medium range adult and neonatal intensive care ventilators, anesthesia machines and through the acquisition of the Pulsion AG advanced hemodynamic monitoring solutions for cardiology, diabetes and lactose management in ICUs and ORs.My contribution:Definition and execution of the global portfolio strategy for all critical care products and solutions. Full global P/L responsibility for the Business Unit and the R&D investment pipeline (NS, GP, Expenses, EBITA).Cross-functional leadership executed in a matrix set-up for approximately 500 Stockholm-based employees in R&D, Operations/Supply Chain, Product Management, Business Management, HR and Finance.Responsible for the post-merger integration of the Pulsion AG advanced monitoring portfolio into the Maquet business process system, the redirection of the product strategy for specialized parameters towards strong OEM alliances with major, global Patient Monitoring companies and a new supply chain concept.

Lübeck, Schleswig-Holstein, De

Definition and execution of the global segment strategy for the hospital segment (previously called “Dräger Medical”), their customer areas and all their products, services and solutions. As segments being the leading planning and executional dimension in cross-functional resources allocation the responsibility includes the commercial accountability for the timely and in-budget development of the R&D roadmaps, the global operative marketing plan, all related planning tasks and the regional roll-out of the associated global market strategies worldwide.

Lübeck, Schleswig-Holstein, De

Major responsibilities included the definition and execution of the global portfolio strategy for the biggest of all Device Business Fields, Anaesthesia Systems, creation of the product roadmap, business related planning tasks and management of the associated global market strategy. Shared global P/L responsibility for the strategic business field and all its product groups and as a consequence the ownership of the investment pipeline (functional expenses, global R&D) and the global profitability (globalGP, EBIT, EVA)

Charged with executing turnaround of major sales and service subsidiary, during period of significant change following divestment of 10-year Joint Venture.• Direct reporting line to the Group CEO and owner of the company, responsible for the 100% subsidiary in this second biggest healthcare market in the world • Successfully executed two-year reengineering/reorganization project "Roadmap to Change" comprised of 150+ projects impacting structure, processes and sales direction; gaining significant improvements in transparency, local management and staff, internal audit rating, supply chain and company culture. • Achieved net sales growth of 10% (2005–2007), despite divestment of joint venture.• Introduced improved IT processes including SAP, Sales, Service and financial platforms.• Positioned subsidiary for future growth through new channel strategy, market analysis, and introduction of Global Subsidiary Framework for the local 165 employees.• Completed first ISO certification (9001:2000, 13485) since opening of branch in 1983. • Positioned DMJ in Japanese community of medical device companies as fastest improving foreign medical manufacturer and significantly elevated brand awareness and public perception.

Lübeck, Schleswig-Holstein, De

Industry: Medical Devices, Perioperative Care Technology including Anesthesia, Monitoring, clinical IT, Architectural Systems, ConsumablesPublicly held corporation, 5,001-10,000 employeesLine-of -business responsibility for all global commercial and marketing aspects of this 400+Mio Euro Business Unit, Deputy Head of Care Area (Business Unit), additional Head of global Strategic Marketing Board (Portfoliomanagement, strategic marketing development) & Work Process Owner in Innovationsmanagementprocess

Lübeck, Schleswig-Holstein, De

Industry: Medical Devices, 51-200 employeesmore general management duties in addition to sales & marketing responsibility of subsidiary, Acquisition and Integration of 2 local Service Providers

after University graduation various positions held in various business areas, starting in Financial Controlling (one of the majors), leading to sales as a rookie and continously transferring into the area of Product Management (downstream marketing/R&D related) and segment marketing (down- and up stream), own projects and global system/product responsibility in the area of Anesthesia Delivery Systems and Monitoring, constantly growing into more global tasks of product marketing and sales/service

Artificial Intelligence: Implications For Business Strategy

Executive Training: Entrepreneurship & Leading Change

Executive Training: Business Administration & Leadership

Wirtschaftsingenieur / Industrial Engineering